Laura M. Daniel

Array ( [id] => 9113317 [patent_doc_number] => 08569491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Method for preparing entecavir and intermediate used therein' [patent_app_type] => utility [patent_app_number] => 13/501414 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9012 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626611 [patent_doc_number] => 08796292 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Selective antibacterials for clostridium difficile infections' [patent_app_type] => utility [patent_app_number] => 13/395296 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8119 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278484 [patent_doc_number] => 20120172347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => '8-OXODIHYDROPURINE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/395429 [patent_app_country] => US [patent_app_date] => 2010-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80507 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007964 [patent_doc_number] => 20110059995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'SUBSTITUTED XANTHINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/874049 [patent_app_country] => US [patent_app_date] => 2010-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 41316 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059995.pdf [firstpage_image] =>[orig_patent_app_number] => 12874049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8394206 [patent_doc_number] => 20120232047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'SUBSTITUTED CLAVULANIC ACID' [patent_app_type] => utility [patent_app_number] => 13/395606 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16101 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153832 [patent_doc_number] => 08586738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Process for the preparation of valganciclovir hydrochloride' [patent_app_type] => utility [patent_app_number] => 13/390756 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2522 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8348068 [patent_doc_number] => 20120208994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'AZETIDINONE COMPOUNDS AND MEDICAL USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/389932 [patent_app_country] => US [patent_app_date] => 2010-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14470 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371380 [patent_doc_number] => 20120220769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE' [patent_app_type] => utility [patent_app_number] => 13/389029 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5029 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10057264 [patent_doc_number] => 09096610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Method for the production of ceftobiprole medocaril' [patent_app_type] => utility [patent_app_number] => 13/320414 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4215 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10103822 [patent_doc_number] => 09139597 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Method for the production of ceftobiprole medocaril' [patent_app_type] => utility [patent_app_number] => 13/320430 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5163 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6599476 [patent_doc_number] => 20100292255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Therapeutic Compounds and Their Use in Treating Diseases and Disorders' [patent_app_type] => utility [patent_app_number] => 12/780828 [patent_app_country] => US [patent_app_date] => 2010-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49940 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292255.pdf [firstpage_image] =>[orig_patent_app_number] => 12780828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8141317 [patent_doc_number] => 20120095209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'INTERMEDIATE OF ERTAPENEM, A COMPOSITION COMPRISING THE SAME AND PREPARATION METHODS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/266947 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3241 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20120095209.pdf [firstpage_image] =>[orig_patent_app_number] => 13266947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9844381 [patent_doc_number] => 08946296 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use' [patent_app_type] => utility [patent_app_number] => 13/500687 [patent_app_country] => US [patent_app_date] => 2010-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 29077 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831386 [patent_doc_number] => 08859555 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Lysine Specific Demethylase-1 inhibitors and their use' [patent_app_type] => utility [patent_app_number] => 13/497994 [patent_app_country] => US [patent_app_date] => 2010-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 36476 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 317 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9996089 [patent_doc_number] => 09040688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-26 [patent_title] => 'Intermediates in the preparation of 1,4-diphenyl azetidinone' [patent_app_type] => utility [patent_app_number] => 13/260877 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3289 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13260877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791635 [patent_doc_number] => 20120053191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS' [patent_app_type] => utility [patent_app_number] => 13/257750 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11530 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053191.pdf [firstpage_image] =>[orig_patent_app_number] => 13257750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8302173 [patent_doc_number] => 20120184731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'Method for synthesizing beta lactam compounds by decomposition of an alpha-diazo-beta-ketoamide using a fluorescent light source' [patent_app_type] => utility [patent_app_number] => 13/255973 [patent_app_country] => US [patent_app_date] => 2010-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12039 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744874 [patent_doc_number] => 20120022248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'B-LACTAM COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/255970 [patent_app_country] => US [patent_app_date] => 2010-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11142 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022248.pdf [firstpage_image] =>[orig_patent_app_number] => 13255970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10506099 [patent_doc_number] => 09233963 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-12 [patent_title] => 'Method for preparing meropenem using zinc powder' [patent_app_type] => utility [patent_app_number] => 13/256178 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5041 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10182502 [patent_doc_number] => 09212175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-15 [patent_title] => 'Pharmaceutical hypocholesterolemic compositions' [patent_app_type] => utility [patent_app_number] => 13/254992 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12586 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13254992 [rel_patent_id] =>[rel_patent_doc_number] =>)